Clinical Trial Update: Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

View source ↗

Summary

A post-market clinical follow-up study for EVOLUTION NitrX keeled tibia and CS/CR femur with a cruciate-sacrificing insert is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Knee
• Osteoarthritis of the Knee
• Rheumatoid Arthritis of the Knee

Snippet

Sponsor: MicroPort Orthopedics Inc. | Conditions: Osteoarthitis, Arthritis Knee | Status: ACTIVE_NOT_RECRUITING